CA3237180A1 - Administration de r-beta-hydroxybutyrate et de composes apparentes chez l'etre humain - Google Patents

Administration de r-beta-hydroxybutyrate et de composes apparentes chez l'etre humain Download PDF

Info

Publication number
CA3237180A1
CA3237180A1 CA3237180A CA3237180A CA3237180A1 CA 3237180 A1 CA3237180 A1 CA 3237180A1 CA 3237180 A CA3237180 A CA 3237180A CA 3237180 A CA3237180 A CA 3237180A CA 3237180 A1 CA3237180 A1 CA 3237180A1
Authority
CA
Canada
Prior art keywords
hydroxybutyrate
beta
approximately
composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3237180A
Other languages
English (en)
Inventor
Ryan LOWERY
Jacob Wilson
Terry LACORE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axcess Global Sciences LLC
Original Assignee
Axcess Global Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/367,206 external-priority patent/US12109182B2/en
Application filed by Axcess Global Sciences LLC filed Critical Axcess Global Sciences LLC
Publication of CA3237180A1 publication Critical patent/CA3237180A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Selon divers modes de réalisation, le bêta-hydroxybutyrate, des composés apparentés et/ou un ou plusieurs autres composés peuvent être administrés à un individu afin de provoquer une perte de poids, de provoquer un maintien du poids, d'élever les taux de cétone dans le sang, de maintenir les taux de cétone dans le sang, de réduire les taux de glucose dans le sang, de maintenir les taux de glucose dans le sang, d'améliorer l'énergie, la concentration, l'humeur, les fonctions cognitives ou de soulager des troubles neurologiques ou inflammatoires et/ou des combinaisons de ces effets.
CA3237180A 2021-07-02 2022-07-01 Administration de r-beta-hydroxybutyrate et de composes apparentes chez l'etre humain Pending CA3237180A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/367,206 US12109182B2 (en) 2016-04-19 2021-07-02 Administration of R-beta-hydroxybutyrate and related compounds in humans
US17/367,206 2021-07-02
PCT/US2022/036030 WO2023278881A1 (fr) 2021-07-02 2022-07-01 Administration de r-bêta-hydroxybutyrate et de composés apparentés chez l'être humain

Publications (1)

Publication Number Publication Date
CA3237180A1 true CA3237180A1 (fr) 2023-01-05

Family

ID=84690667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3237180A Pending CA3237180A1 (fr) 2021-07-02 2022-07-01 Administration de r-beta-hydroxybutyrate et de composes apparentes chez l'etre humain

Country Status (3)

Country Link
AU (1) AU2022305262A1 (fr)
CA (1) CA3237180A1 (fr)
WO (1) WO2023278881A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024155950A2 (fr) * 2023-01-20 2024-07-25 Keto Innovations, Llc Compositions de cétone en c5, et méthodes associées, pour un complément thérapeutique et de performance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190313682A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
WO2020092451A1 (fr) * 2018-10-29 2020-05-07 Keto Patent Group, Inc. Administration à l'homme de butyrate, de bêta-hydroxybutyrate, de cannabidiol et de composés apparentés

Also Published As

Publication number Publication date
WO2023278881A1 (fr) 2023-01-05
AU2022305262A1 (en) 2024-07-04

Similar Documents

Publication Publication Date Title
US11173138B2 (en) Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US11969411B2 (en) Administration of berberine metabolites
US20200129463A1 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
KR100545630B1 (ko) 필수 지방산과 생물활성 이황화물을 함유하는 치료 및식이요법 조성물
WO2001021208A1 (fr) Supplement nutritionnel fournissant une energie et une endurance accrues
KR20110135986A (ko) 당뇨병 요법을 지원하기 위한 α-케토산을 포함하는 식이 보충제
CA3237180A1 (fr) Administration de r-beta-hydroxybutyrate et de composes apparentes chez l'etre humain
US20230364042A1 (en) Administration of beta-hydroxybutyrate and related compounds in humans for the treatment and/or prevention of respiratory illnesses
US12109182B2 (en) Administration of R-beta-hydroxybutyrate and related compounds in humans
US20220339142A1 (en) Administration of r-beta-hydroxybutyrate salt blend and related compounds in humans
WO2022071117A1 (fr) Composition anti-fatigue et composition pour améliorer, supprimer la réduction de, et maintenir la performance de production d'énergie
US20220362188A1 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
US20220202789A1 (en) Administration of berberine metabolites
WO2023212319A1 (fr) Administration d'un mélange de sels de r-bêta-hydroxybutyrate et de composés apparentés chez l'homme
WO2023081409A1 (fr) Administration de métabolites de berbérine
US20220249419A1 (en) C5 ketone compositions, and related methods, for therapeutic and performance supplementation
WO2023211755A1 (fr) Compositions de cétone en c5, et méthodes associées, pour un complément thérapeutique et de performance
US20230346699A1 (en) Administration of r-beta-hydroxybutyrate and related compounds in veterinary applications
WO2023026043A1 (fr) Compositions nutritionnelles